Exicure (XCUR) Climbs 1.1% to $1.09 as Biotech Peers Show Mixed GainsExicure (XCUR) posts a modest 1.1% gain to $1.09 after a steep fall, amid mixed biotech peers and a slow rebound toward its 200‑day MA.EXICURE INCUnited States Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Jake Connors 23/10/2026, 19:30 2 minutes to read
Exicure Shares Drop 3.01% as Biotech Market Remains Volatile – Key Figures & Peer ComparisonExicure shares fell 3.01% to $1.02, reflecting broader biotech caution amid regulatory scrutiny and trial results.EXICURE INCUnited States Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Jake Connors 21/10/2026, 21:26 2 minutes to read